“…Nevertheless, when such cells were interacted in the absence of added serum with human monocyte-derived M , no defect in phagocytosis of apoptotic neutrophils was observed despite functionally validated Ab blockade of M , CR1, CR3, and CR4 receptors (38), nor was any obvious defect in phagocytosis exhibited by monocyte-derived M prepared from a patient with severe congenital  2 deficiency (40). However, our findings must be set against 1) growing evidence that the first component of complement, C1q, could bridge apoptotic cells to phagocytes in a manner similar to that proposed for TSP1 (41,42), and 2) compelling data suggesting that M receptors for opsonic complement fragments could be important in amplifying efficient phagocytosis of dying cells (17,29). Nevertheless, it is notable that these latter reports have either used mixed populations of dying cells, including cells in secondary necrosis (17), or have used assays of interaction with M that include a large tethering element (29) rather than our own extensively validated assay of completed phagocytosis.…”